AU2002352479A1 - 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus - Google Patents
5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitusInfo
- Publication number
- AU2002352479A1 AU2002352479A1 AU2002352479A AU2002352479A AU2002352479A1 AU 2002352479 A1 AU2002352479 A1 AU 2002352479A1 AU 2002352479 A AU2002352479 A AU 2002352479A AU 2002352479 A AU2002352479 A AU 2002352479A AU 2002352479 A1 AU2002352479 A1 AU 2002352479A1
- Authority
- AU
- Australia
- Prior art keywords
- thiazolidine
- dione
- pyridyl
- ethoxy
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- -1 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt Chemical class 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0130506.9 | 2001-12-20 | ||
| GB0130506A GB0130506D0 (en) | 2001-12-20 | 2001-12-20 | Novel compounds |
| GB0130508A GB0130508D0 (en) | 2001-12-20 | 2001-12-20 | Novel compounds |
| GB0130507.7 | 2001-12-20 | ||
| GB0130508.5 | 2001-12-20 | ||
| GB0130507A GB0130507D0 (en) | 2001-12-20 | 2001-12-20 | Novel compounds |
| PCT/GB2002/005814 WO2003053962A1 (en) | 2001-12-20 | 2002-12-19 | 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002352479A1 true AU2002352479A1 (en) | 2003-07-09 |
Family
ID=27256359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002352479A Abandoned AU2002352479A1 (en) | 2001-12-20 | 2002-12-19 | 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002352479A1 (en) |
| WO (1) | WO2003053962A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR047541A1 (en) * | 2004-02-13 | 2006-01-25 | Sandoz Ag | PHOSPHATE OF 5 - [[4- [2-METHYL-2-PYRIDINYL-AMINO-ETOXI] PHENYL] METHYL] -2,4 THYZOLIDINADION (ROSIGLITAZONE) AND ITS POLYMORPHIC FORMS |
| DE102005034406A1 (en) * | 2005-07-22 | 2007-02-01 | Ratiopharm Gmbh | New salts of rosiglitazone |
| PL384446A1 (en) * | 2008-02-12 | 2009-08-17 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Salt of 5-[[4-[2-(methyl-2-pyridinamino)ethoxy]phenyl]methyl]-2,4-tiazolidynodion with malonic acid and its production method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0306228B1 (en) * | 1987-09-04 | 1999-11-17 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| GB9726568D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| BR0009934A (en) * | 1999-04-23 | 2002-06-04 | Smithkline Beecham Plc | Pharmaceutical |
-
2002
- 2002-12-19 AU AU2002352479A patent/AU2002352479A1/en not_active Abandoned
- 2002-12-19 WO PCT/GB2002/005814 patent/WO2003053962A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003053962A1 (en) | 2003-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ3316A1 (en) | Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
| MXPA01010821A (en) | Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt. | |
| IL136424A0 (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical | |
| AU9123201A (en) | Novel polymorphic forms of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione maleate and process for their preparation | |
| AP2000001830A0 (en) | Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt | |
| AU2002343036A1 (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same | |
| AU2002352479A1 (en) | 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus | |
| AU8428401A (en) | The hydrochloride salt of 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione | |
| AU2002352481A1 (en) | 5- (4- (2- (n-methyl-n- (2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione nephtalenesulfonate salt and use against diabetes mellitus | |
| AU2002343052A1 (en) | Rosiglitazone edisylates and their use as antidiabetics | |
| AP1814A (en) | Tartrate salts of thiazolidinedione derivative. | |
| IL188116A0 (en) | Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione | |
| AU6255001A (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical | |
| AU2002352391A1 (en) | A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus | |
| MXPA02012100A (en) | Thiazolidinedione salt for treatment of diabetes mellitus. | |
| AU2001284285A1 (en) | A thiazolidinedione derivative and its use as antidiabetic | |
| HK1055294A (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical | |
| AP1785A (en) | Tartrate salt of thiazolidinedione derivative. | |
| AP1841A (en) | A thiazolidinedione derivative and its use as antidiabetic. | |
| SI1265893T1 (en) | Hydrochloride salts of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione | |
| HK1068883A (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical compositions comprising the same | |
| HK1032905A (en) | 5-[4-[2-(n-methyl-n-(2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical | |
| SI1173435T1 (en) | Polymorph of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleic acid salt | |
| HK1059259A (en) | Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione | |
| AU2002222305A1 (en) | 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |